INTERNATIONAL PATENT: GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD., GENEQUANTUM MEDICINE (SUZHOU) CO., LTD. FILES APPLICATION FOR "ENZYME-CATALYZED SITE-SPECIFIC ANTIBODY-OLIGONUCLEOTIDE CONJUGATES (AOCS) CONJUGATION METHOD"

GENEVA, March 16 -- GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (5th Floor, Building D, No. 398, Ruoshui Rd., Suzhou Industrial ParkSuzhou, Jiangsu 215123), GENEQUANTUM MEDICINE (SUZHOU) CO., LTD. (Building 4, Fumin III Plant, No.818 Wusong Road, Wuzhong DistrictSuzhou, Jiangsu 215124) filed a patent application (PCT/CN2025/119775) for "ENZYME-CATALYZED SITE-SPECIFIC ANTIBODY-OLIGONUCLEOTIDE CONJUGATES (AOCS) CONJUGATION METHOD" on Sep 08, 2025. With publication no. WO/2026/052110, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invento...